INTRODUCTION
Binding of TCR to peptide-MHC (pMHC) complex is the key step for T cell activation and cellular immune responses (1) . Efficient triggering of T cell responses critically depends on the strength of TCR-mediated antigen recognition, namely it has been shown that strong binding to pMHC confers superior effector function than weak interactions (2) (3) (4) (5) (6) (7) . This is of particular interest for immunotherapy based on adoptive T cell transfer, aiming to convey immune reactivity against tumor-associated antigens, for which endogenous T cell responses are usually weak. Many tumor antigens are in fact self-antigens that are expressed in the thymus, and accordingly, most tumor-reactive T cells of high avidity become negatively selected, in contrast to pathogen-specific T cells (8) . Therefore, there is a need for a robust technology that allows rapid identification and isolation of CD8+ T cells expressing TCRs capable to efficiently activate and enhance T cell function against malignant cells.
TCR-pMHC binding parameters are typically assessed by SPR, which requires laborious and expensive production of soluble TCRs and ignores the TCR-pMHC avidity effects related to CD8 co-receptor binding. On the other hand, kinetic measurements using pMHC tetramers or multimers have been extensively studied on the surface of antigen-specific CD8+ T cells, but due to the multivalent and heterogeneous composition of these multimers, this approach does not allow to accurately determine TCR-pMHC dissociation rates (9) . Binding and dissociation measurements should ideally be performed using monomeric pMHC complexes. Because TCRpMHC interactions typically exhibit weak affinities and fast dissociation rates, this has long precluded conclusive measurements with monomeric pMHCs (10).
Nauerth et al. (11) recently measured monomeric TCR-pMHC dissociation kinetics using reversible Streptamers and reported that virus-specific CD8+ T cells with longer half-lives (low 4 Hebeisen et al., v20150203 k off rates) conferred increased functional avidity and better in vivo protection than T cells exhibiting shorter t 1/2 (high k off rates). However, the Streptamer assay (11) needs a significant lag time until monomeric TCR-pMHC dissociation starts to become detectable, limiting thereby off-rate analyses to antigen-specific T cells of relative long half-lives, typically found in immune responses against pathogens. Moreover, accurate measurements of TCR-pMHC binding parameters on living T cells (11) (12) (13) (14) require specialized equipment, which is currently not available for the high-throughput screen of antigen-specific T cell populations.
To overcome these limitations, we here applied pMHC multimers built on reversible chelate complexes of Ni 2+ -nitriloacetic acid (NTA) with oligohistidines (15) allowing the efficient and direct cytometry-based assessment of monomeric TCR-pMHC dissociation kinetics on the surface of (self) tumor-specific CD8+ T cells. We found that the NTAmer technology accurately predicted T cell biological responses within a large panel of tumor-specific T cell clones, providing novel means for the direct isolation of rare functionally relevant CD8+ T cells for adoptive cell transfer therapy.
Hebeisen et al., v20150203

MATERIALS AND METHODS
Ethics statement
The three HLA-A*0201-positive patients had stage III/IV metastatic melanoma and were included in immunotherapy studies (patient LAU 50, NCT00112242; patient LAU 155, NCT00002669; and patient LAU 618, NCT00112229; www.clinicaltrials.gov). The studies were designed and conducted according to the relevant regulatory standards, upon approval by the ethical commissions and regulatory agency of Switzerland. Patient recruitment, study procedures, and blood withdrawal were done upon written informed consent.
Primary bulk CD8+ T cells and generation of tumor-specific CD8+ T cell clones
Human primary HLA-A*0201 pos CD8+ T lymphocytes were obtained following positive enrichment using anti-CD8-coated magnetic microbeads (Miltenyi Biotec), and cultured in RPMI supplemented with 8% human serum (HS) and 150 U/ml recombinant human IL-2. 
NTAmer production and staining
NTAmers were synthetized by TCMetrix Sàrl (www.tcmetrix.ch) as described in (15 were mixed at a 10-fold ratio with SA-PE-NTA 4 in the presence of Ni 2+ as described in (15) . The same procedure was used to prepare CD8-binding deficient HLA-A*0201 monomers bearing the D227K/T228A mutations in the HLA-α3 domain (17) . Dually labeled NTAmers containing SA-PE and Cy5-labeled monomers were used for dissociation kinetic measurements as described below.
Single labeled NTAmers containing SA-PE and unlabeled monomers were used for flow cytometry- 
Dissociation kinetic data analysis
Flow cytometry-based data were processed using the FlowJo software (v.9.6, Tree Star, Inc.). After gating on living cells, PE or Cy5 mean fluorescence intensity was derived using the kinetic module of the FlowJo software. Gates of 6 seconds period were created following addition of imidazole at the following time-points; 15s, 30s, 45s, 60s, 90s, 120s and then every minute for 10 minutes. 
Chromium release and tumor recognition assays
The functional avidity of antigen recognition was analyzed in a 4-hour 51 Cr-release assay using 
Statistics
Statistical analyses were done with the GraphPad Prism software. A minimum of three independent experiments were performed to ensure a statistical power of 100% at α = 0.05 (Fig. 2 and 3), and a sample size ≥ 23 to ensure a statistical power of 80% at α = 0.05 (Fig. 5 ).
Correlation analyses were performed using Pearson ( Fig. 2 to 4) or Spearman (Fig. 5 ) coefficient r. The associated p value (two-tailed, α = 0.05) quantifies the likelihood that the correlation is due to random sampling. Two different investigators performed each TCR-pMHC dissociation kinetic experiment independently, and experiments described in Figure 5 were performed blinded for both sample allocation and outcome assessment.
RESULTS
Direct measurements of monomeric TCR-pMHC dissociation kinetics by NTAmers
We previously developed a method for the isolation and analysis of antigen-specific cytotoxic T cells by reversible NTAmers (10, 15) . Upon addition of imidazole at low, non-toxic concentration, the SA-PE-NTA 4 moieties rapidly decay (average dissociation half-life of 2.5 sec), thereby releasing the pMHC monomers bound at the cell surface. Consequently, NTAmers allow FACS-sorting of CD8+ T cells without inducing adverse effects on the cell integrity (e.g.
activation-induced cell death) (10, 15) . Taking advantage of the fact that NTAmers can be switched from stable binding to rapid dissociation, a two-color NTAmer was engineered to assess monomeric TCR-pMHC dissociation kinetics directly on living CD8+ T cells (Fig. 1A ).
We first evaluated this novel approach by direct visualization of the dissociation process on within the physiological range (e.g. V49I, wild-type and DMβ). To solve this issue, we used a conventional flow cytometer (LSRII-SORP) equipped with a thermostat, which drastically reduced the lagging time to less than 5 sec (Fig. 1C) , thereby allowing the accurate assessment of monomeric pMHC dissociation kinetics on the surface of CD8+ T cells across a wide TCR affinity spectrum (Fig. 1D , Supplementary Fig. S1A ). To validate the NTAmer technology, we next compared these dissociation values with SPR kinetics data obtained with the corresponding soluble TCRs (Table 1) . Robust correlations were found between NTAmer-based cell surface monomeric pMHC dissociation kinetics (half-live t 1/2 and k off ), with both k off rates and affinities measured by SPR, contrasting with the weaker correlations obtained with pMHC tetramers (Fig.   2A , Supplementary Fig. S2A ).
CD8 co-receptor stabilized the TCR-pMHC complex by prolonging the dissociation half-life by a factor of 3 to 4-fold
To precisely quantify the contribution of CD8 co-receptor to monomeric TCR-pMHC dissociation, we generated NTAmer 227-228 variants containing the HLA-A*0201 D227K/T228A mutations in the MHC α3 domain that abolish CD8 binding to pMHC (17) . Using the same panel of TCR transduced CD8+ SUP-T1 cells we show that abrogating CD8-MHC binding drastically diminished dissociation half-lives (t 1/2 ) over the whole spectrum of TCR affinities (Fig. 2B , Supplementary Fig. S1B and C). Monomeric off-rate (k off and t 1/2 ) correlations between NTAmers 227-228 and SPR were highly significant ( Fig. 2A, Supplementary Fig. S2A ).
Comparison between wild-type and CD8-binding deficient NTAmer-based half-lives revealed that CD8 stabilized by a factor of 3 to 4-fold the interaction between tumor-specific TCRs and HLA-A*0201/NY-ESO-1 irrespectively of the TCR affinity (Fig. 2B) . A similar effect of CD8 binding to pMHC was observed when using TCR transduced Jurkat T cells that lack CD8 expression ( Fig. 2C and D those typically found within the self/tumor-specific repertoires, and (ii) the quantification of the contribution of CD8 binding on the TCR-pMHC complex stability, which is not possible in SPR measurements.
Monomeric TCR-pMHC dissociation kinetics correlate with enhanced T cell responsiveness
Next we compared k off rates obtained using NTAmers and the intracellular calcium mobilization on CD8+ SUP-T1 cells (Fig. 3A and B) and primary CD8+ T cells (Fig. 3D and E) expressing the panel of affinity-optimized TCRs against NY-ESO-1 tumor antigen. In line with our previous reports (19, 20) , the Ca 2+ flux was enhanced with increasing TCR affinity, up to reaching a plateau, while further affinity increase (K D < 1 µM) resulted in reduced calcium signaling.
Within the physiological TCR-pMHC affinity range, however, both SUP-T1 cells and primary T cells exhibited strong correlations between dissociation rates and Ca 2+ mobilization ( was observed when using mutant multimer/HLA-A*0201 227-228 for specific stimulation, but this effect was less stringent for T cells expressing very high TCR affinities (e.g. TMα, QMα and wtc51m) (Fig. 3A and B) . As previously reported (20) (21) (22) , these data indicate that the degree of CD8 dependence for T cell activation inversely depends on the affinity and dissociation half-life of the TCR-pMHC interaction.
We extended these observations to a clinically relevant setting, and characterized k off rates and functional avidity of T cells obtained from a large set of HLA-A*0201/NY-ESO-1 157-165 -specific CD8+ T cell clones expressing well-defined TCRαβ clonotypes derived from LAU 155, a melanoma patient with long lasting anti-tumor T cell responses (16) . The dissociation rates of those cytotoxic T cell clones clustered within a narrow range (Fig. 4A, Supplementary Fig. S3A ), and strongly correlated with EC 50 target cell killing (50% maximal lysis; Fig. 4C ) and tumor cell recognition (Fig. 4E) , with TCR clonotypes having long half-lives (low k off ) exhibiting increased T cell cytotoxicity (Fig. 4B and D) . Conversely, NY-ESO-1-specific TCR clonotypes with short half-lives (high k off ) showed reduced T cell killing capacities. Fig. S4 ). Next, we performed killing assays with 57 clones selected for relatively low or high k off values (Fig. 5B and E) . We observed, for both antigenic specificities, a robust correlation between off-rates and the functional avidity (EC 50 ) determined with the cytotoxicity assay (Fig. 5C and F) , demonstrating that NTAmers allow reliable assessment of surface-based TCR-pMHC dissociation kinetics and rapid selection of highly potent tumorspecific T cell clones derived from different cancer patients. demonstrate that NTAmer-based off-rates (k off , t 1/2 ) followed the same TCR-pMHC binding hierarchy than previously established (20) , in excellent agreement to both binding parameters, k off and the dissociation constant K D , obtained by SPR ( Fig. 2 ; Table 1 ).
DISCUSSION
Due to their switch ability i.e. high stability and rapid reversibility (< 5 sec), NTAmers allowed accurate determination of dissociation rates, even for weak TCR-pMHC interactions, i.e. fast offrates, such as those found for (self) tumor-specific CD8+ T cell repertoires (Fig. 4) . Notably, the NTAmer approach differs from the Streptamer one, which is mostly limited to the detection of CD8+ T cells of high avidity such as virus-specific cells, as it requires a significant lag time (60 sec) before monomeric TCR-pMHC dissociation becomes detectable (11) . Moreover, the (Fig. 5) . Importantly, we demonstrate robust correlations between dissociation off-rates and the biological responses (e.g calcium flux and target cell killing) on a large panel of CD8+ T cell clones specific for two distinct tumor antigens, indicating that TCRligand k off rate is a reliable predictor of T cell function (Fig. 3-5 ).
Interactions between TCRs and pMHC are usually measured by SPR or pMHC tetramer or multimer staining, which requires one binding partner in soluble form. Both approaches have caveats. Due to their incomplete dissociation and multivalent nature, accurate off-rates data from pMHC tetramer/multimer staining measurements are imprecise. Conversely, monomeric dissociation k off rates measured by the NTAmer technology were within the range of seconds to minutes, spanning a broad range (2-logs), as compared to a narrow range of minutes observed when using pMHC tetramers. Moreover, SPR fails to take into account rapid rebinding of the TCR to the same pMHC, because one of the two binding partners is constantly moving in the fluid phase, which impacts on the binding kinetics. Increased k on rates have been shown to allow rapid rebinding after TCR-ligand dissociation, resulting in enhanced effective dissociation halflife of the TCR-pMHC interaction (25, 27) . This may explain our observation that TCR variants with faster k on (e.g. TMα and QMα) showed prolonged NTAmer-based dissociation half-lives compared to soluble monomeric off-rates measured by SPR (Table 1 , Supplementary Fig. S5 ).
The NTAmer-based approach further deviates from SPR measurements, as it provides data on living cells and includes contributions of CD8 to TCR-pMHC interactions. The CD8 co-receptor enhances antigen recognition and T cell activation by stabilizing TCR-pMHC interaction at the cell surface (28-31) and recruiting p56 lck to TCR/CD3 complex promoting cell signaling (32, 33 ).
Here we demonstrate that CD8 strengthened the TCR-pMHC binding mainly by decreasing the TCR-pMHC dissociation by a factor of 3 to 4-fold (Fig. 2) , as anticipated by previous tetramer dissociation assays (22, 30) . Interestingly, the CD8 stabilization factor was independent of the TCR-pMHC affinity, in contrast to the CD8 dependence for T cell activation, which can be directly linked to the affinity (3, 20, 22) , and allows tuning the sensitivity and specificity of T cell responses (34).
We recently provided new evidence that T cell signaling and activation are optimal within a given TCR-pMHC affinity window (20) , controlled through TCR affinity-mediated regulatory molecules, involving the inhibitory receptor PD-1 and SHP-1 phosphatase (19) . (20).
(b) TCR-pMHC affinity, k off and k on values were previously measured by SPR as reported in (20) . 
(c) CD8+ T cells, TCR-transduced SUP-T1 cells; CD8-T cells, TCR-transduced
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